|
시장보고서
상품코드
2075217
조혈모세포 이식(HSCT) 시장 : 이식 유형별, 적응증별, 용도별, 최종사용자별, 지역별Hematopoietic Stem Cell Transplantation (HSCT) Market, By Transplant Type, By Indication, By Application, By End User, By Region |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
조혈모세포 이식(HSCT) 시장은 2026년에 39억 7,000만 달러 규모에 달할 것으로 추정되고 있으며, 2033년까지 84억 4,000만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 11.4%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 39억 7,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 11.40% | 2033년 시장 규모 예측 : | 84억 4,000만 달러 |
조혈세포 이식(골수 이식 또는 줄기세포 이식이라고도 함)은 암(및 기타 몇 가지 질환)에 대한 치료법 중 하나입니다. 조혈모세포 이식을 이해하려면 골수의 정상적인 기능에 대해 알아보는 것이 도움이 됩니다. 조혈모세포 이식은 암에 대한 가장 효과적인 치료법입니다. 화학요법이나 방사선 요법 등 다른 치료법은 골수에 독성을 일으킵니다. 일반적으로 투여량이 많을수록 골수에 미치는 독성 작용도 강해집니다.
조혈세포 이식에는 주로 자가 이식과 동종 이식의 두 가지 유형이 있습니다. 자가 이식의 경우, 고용량 화학요법이나 방사선 치료를 시행하기 전에 환자 본인의 조혈모세포를 채취하여 보존 및 향후 사용을 위해 냉동 보관합니다. 화학요법이나 방사선 치료가 끝난 후, 채취한 세포를 해동하여 환자에게 투여합니다. 동종 이식의 경우, 조혈모세포는 기증자로부터 제공됩니다. 이상적으로는 유전적 구성이 비슷한 형제자매로부터 기증받는 것이 바람직하다고 여겨집니다.
시장 역학
주요 시장 참여자들의 제품 포트폴리오 확대를 목적으로 한 신제품 출시 등 유기적 성장 전략의 증가가 예측 기간 중 시장 성장을 촉진할 것으로 전망됩니다. 예를 들어 2020년 1월, 유전자 치료 제품을 제공하는 Bluebird Bio, Inc.는 독일에서 수혈 의존성 B형 지중해빈혈(TDT)을 앓고 있는 12세 이상의 환자를 대상으로 한 조혈모세포(HSC) 이식용 1회 투여형 유전자 치료제 ‘ZYNTEGLO'(BA-T87Q-글로빈 유전자를 암호화하는 자가 CD34+ 세포)의 출시를 발표했습니다. ZYNTEGLO의 정식 명칭은 'BA-T87Q-글로빈 유전자를 암호화하는 렌티바이러스 벡터로 형질전환된 조혈모세포를 포함하는 유전자 변형된 자가 유래 CD34+ 세포 농축군'입니다.
본 조사의 주요 특징 :
- 이 보고서는 전 세계 조혈모세포 이식(HSCT) 시장에 대한 상세한 분석을 제공하는 한편, 2025년을 기준 연도로 하여 2026-2033년의 예측 기간 중 시장 규모 및 연평균 성장률(CAGR)을 제시하고 있습니다. 또한 다양한 부문에서 잠재적인 매출 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하는 경쟁 전략에 관한 중요 인사이트도 제공하고 있습니다.
- 이 보고서에서는 다음의 주요 항목(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)을 바탕으로 전 세계 조혈모세포 이식(HSCT) 시장의 주요 기업 개요을 소개하고 있습니다.
- 이 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있게 됩니다.
- 세계의 조혈모세포 이식(HSCT) 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 조혈모세포 이식(HSCT) 시장 분석에 활용되는 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 조혈모세포 이식(HSCT) 시장 : 이식 유형별, 2021-2033년
제5장 세계의 조혈모세포 이식(HSCT) 시장 : 적응증별, 2021-2033년
제6장 세계의 조혈모세포 이식(HSCT) 시장 : 용도별, 2021-2033년
제7장 세계의 조혈모세포 이식(HSCT) 시장 : 최종사용자별, 2021-2033년
제8장 세계의 조혈모세포 이식(HSCT) 시장 : 지역별, 2021-2033년
제9장 경쟁 구도
제10장 섹션
KSA 26.07.07Hematopoietic stem cell transplantation (HSCT) market is estimated to be valued at USD 3.97 Bn in 2026 and is expected to reach USD 8.44 Bn by 2033, growing at a compound annual growth rate (CAGR) of 11.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 3.97 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 11.40% | 2033 Value Projection: | USD 8.44 Bn |
Hematopoietic cell transplantation (also called bone marrow transplantation or stem cell transplantation) is a type of treatment for cancer (and a few other conditions as well). A review of the normal function of the bone marrow will help in the understanding of stem cell transplantation. Hematopoietic cell transplantation is the most effective treatment for cancer. Other treatments, such as chemotherapy and radiation, are toxic to the bone marrow. In general, the higher the dose, the more toxic the effects on the bone marrow.
There are two main types of hematopoietic cell transplantation: autologous and allogeneic. In autologous transplantation, the patient's own hematopoietic stem cells are removed before high-dose chemotherapy or radiation is given, and they are then frozen for storage and later use. After chemotherapy or radiation is complete, the harvested cells are thawed and returned to the patient. In allogeneic transplantation, the hematopoietic stem cells come from a donor, ideally a brother or sister with a similar genetic makeup.
Market Dynamics
The increasing organic growth strategies, such as product launches by key market players to expand their product portfolio are expected to drive market growth over the forecast period. For instance, in January 2020, Bluebird Bio, Inc., a company providing gene therapy products, announced the launch of ZYNTEGLO (autologous CD34+ cells encoding BA-T87Q-globin gene), a one-time gene therapy for patients 12 years of age and older with transfusion-dependent B-thalassemia (TDT) for hematopoietic stem cell (HSC) transplantation in Germany. The full common name for ZYNTEGLO is a genetically modified autologous CD34+ cell-enriched population that contains hematopoietic stem cells transduced with a lentiviral vector encoding the BA-T87Q-globin gene.
Key features of the study:
- This report provides an in-depth analysis of the global hematopoietic stem cell transplantation (HSCT) market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period 2026-2033, considering 2025 as the base year It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global hematopoietic stem cell transplantation (HSCT) market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Pluristem Therapeutics Inc., CellGenix GmbH, Regen Biopharma Inc., Lonza Group, Kiadis Pharma, Taiga Biotechnologies, Inc., Takeda Pharmaceutical Company Limited, Escape Therapeutics, Inc., Bluebird Bio, Inc., Talaris Therapeutics, Inc., Marker Therapeutics Inc., Stempeutics Research Pvt Ltd., CBR Systems Inc., Priothera Ltd., Eurobio Scientific Group, Otsuka America Pharmaceutical, Inc., Pfizer Inc., Sanofi, FUJIFILM Holdings Corporation
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global hematopoietic stem cell transplantation (HSCT) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hematopoietic stem cell transplantation (HSCT) market
Detailed Segmentation:
- Global Hematopoietic Stem Cell Transplantation (HSCT) Market , By Transplant Type (Revenue, USD Bn, 2021 - 2033)
- Allogeneic
- Autologous
- Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By Indication (Revenue, USD Bn, 2021 - 2033)
- Acute Myeloid Leukemia (AML)
- Acute Lymphoblastic Leukemia (ALL)
- Hodgkin lymphoma (HL)
- Non-Hodgkin Lymphoma (NHL)
- Multiple Myeloma (MM)
- Others
- Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By Application (Revenue, USD Bn, 2021 - 2033)
- Bone Marrow Transplant (BMT)
- Peripheral Blood Stem Cells Transplant (PBSCT)
- Cord Blood Transplant (CBT)
- Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By End User (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Specialty Clinics
- Others
- Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By Region (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Pluristem Therapeutics Inc.
- CellGenix GmbH
- Regen Biopharma Inc.
- Lonza Group
- Kiadis Pharma
- Taiga Biotechnologies, Inc.
- Takeda Pharmaceutical Company Limited
- Escape Therapeutics, Inc.
- Bluebird Bio, Inc.
- Talaris Therapeutics, Inc.
- Marker Therapeutics Inc.
- Stempeutics Research Pvt Ltd.
- CBR Systems Inc.
- Priothera Ltd.
- Eurobio Scientific Group
- Otsuka America Pharmaceutical, Inc.
- Pfizer Inc.
- Sanofi
- FUJIFILM Holdings Corporation
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Transplant Type
- Market Snippet, By Indication
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Test Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By Transplant Type, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Allogeneic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Autologous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
5. Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By Indication, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Acute Myeloid Leukemia (AML)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Acute Lymphoblastic Leukemia (ALL)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Hodgkin lymphoma (HL)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Non-Hodgkin Lymphoma (NHL)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Multiple Myeloma (MM)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
6. Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By Application, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Bone Marrow Transplant (BMT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Peripheral Blood Stem Cells Transplant (PBSCT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Cord Blood Transplant (CBT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
7. Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By End User, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
8. Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By Region, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Transplant Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication, 2021 -2033, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Transplant Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication, 2021 -2033, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Transplant Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication, 2021 -2033, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Transplant Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication, 2021 -2033, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Transplant Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication, 2021 -2033, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Transplant Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Indication, 2021 -2033, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2021 -2033, (US$ Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- Pluristem Therapeutics Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- CellGenix GmbH
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Regen Biopharma Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Lonza Group
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Kiadis Pharma
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Taiga Biotechnologies, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Takeda Pharmaceutical Company Limited
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Escape Therapeutics, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Bluebird Bio,Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Talaris Therapeutics, Inc.,
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Marker Therapeutics Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Stempeutics Research Pvt Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- CBR Systems Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Priothera Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Eurobio Scientific Group
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Otsuka America Pharmaceutical, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Sanofi
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- FUJIFILM Holdings Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Pluristem Therapeutics Inc.
10. Section
- References
- Research Methodology
- About us and Sales Contact
